The global IOL market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period. The key factor contributing to the market growth includes the rising adoption of strategic initiatives by major companies operating in the market to strengthen their market position. Strategic initiatives include mergers, acquisitions, and product launches of new technology-based products. Owing to the integration of technology consumer demand for such products has increased over the past few years. For instance, in January 2022, Alcon Vision LLC launched presbyopia-correcting (PC-IOL) the AcrySof IQ Vivity IOL to Indian ophthalmologists for patients undergoing cataract surgery. The new IOLs are designed with Alcon's proprietary X-WAVE technology. Additionally, in November 2020, Alcon Vision LLC showcased several innovations in IOLs and digital health solutions. AcrySof, IQ Vivity, IOL, and the AcrySof, IQ PanOptix Trifocal IOL, including the new cloud-based surgical planning application, the SMARTCataract Planner. In May 2020, Bausch + Lomb launched the first presbyopia-correcting and monofocal IOL, named as LuxSmart and LuxGood, respectively. Both the new products are featured with pre-loaded delivery systems and the new IOL range utilizes Pure Refractive Optics (PRO) technology.
Browse the full report description of “Intraocular Lens (IOLs) Market Size, Share & Trends Analysis Report by Product Type (Monofocal IOLs, Multifocal IOLs, Toric IOLs, and Accommodative IOLs), and by End-User (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, and Eye Research Institutes) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/intraocular-lens-iols-market
Furthermore, government and non-government organizations are majorly focusing on research in the ophthalmic domain. These organizations are increasingly focusing on spreading awareness programs and campaigns on symptoms of cataracts and other eye-related disorders owing to such initiatives people opting for various cataract surgeries and the market is growing further. For instance, in May 2022, Medtech start-up VisusNano was awarded $1.5 million from the UK Biomedical Catalyst program to develop MEDILens, a drug-eluting (IOL) implant. The company has also received match funding from Discovery Park Ventures and Oxford Investment Opportunity Network (OION). As per the data published by State Health Society Chandigarh under the National Program for Control of Blindness (NPCB), in January 2022, around 5099 cataract operations against the target of 6961 were performed under which 5096 IOLs implantations were undertaken.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product Type
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Alcon Vision LLC, Bausch + Lomb Corp., HOYA Medical Singapore Pte. Ltd., Johnson & Johnson Vision Care, Inc., Lenstec, Inc., STAAR Surgical Co., and ZEISS group, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Intraocular Lens (IOL) Market Report by Segment
By Product Type
By End-User
Global Intraocular Lens (IOL) Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/intraocular-lens-iols-market